BusinessFluidigm Announces Preliminary Revenue for the Fourth Quarter and Full Year Ended December 31, 2016By Nasdaq OMXJan 9, 2017, 9:15 PM UTC
BusinessFluidigm Introduces High-Parameter Maxpar Mass Cytometry Panels for Immuno-Oncology ResearchBy Nasdaq OMXNov 10, 2016, 1:30 PM UTC
